Medtronic and Volcano Corporation. Peripheral vascular devices Market Outlook Peripheral vascular devices are gadgets used in the diagnosis and management of diseases of the blood vessels other ...
Medtronic announced results from two studies evaluating the utility of atherectomy for peripheral endovascular interventions.
NEW HOPE, Pa., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical innovation company accelerating high-impact ...
Medtronic and Recor Medical each announced separate Medicare reimbursement approvals for their respective renal denervation ...
The 2024 edition of Transcatheter Cardiovascular Therapeutics (TCT) once again highlighted significant innovations in ...
Zacks.com on MSN5d
Medtronic Stock Trading at a Discount Before Q2 Earnings: Time to Buy?Medtronic plc MDT is scheduled to report second-quarter fiscal 2025 results on Nov. 19, before the opening bell. In the last reported quarter, the company’s adjusted earnings of $1.23 exceeded the ...
A pediatric arterial filter for the most magical patients, the Affinity Pixie arterial filter features ease of prime and effective air handling and filtration. The filter’s maximum recommended ...
The Peripheral Vascular devices market is fragmented. A few strong players in this market are Boston Scientific Corporation (U.S.), Medtronic (U.S), Philips (Japan), Merit Medical Systems (U.S ...
Medtronic announced new long-term data from the SPYRAL HTN-ON MED clinical trial of the company’s Symplicity Spyral renal ...
Baxter will share an update on Hurricane Helene’s impact, while Medtronic will likely discuss a new pulsed field ablation ...
Stifel Nicolaus analyst Rick Wise maintained a Buy rating on Lemaitre Vascular (LMAT – Research Report) today and set a price target of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback